Daniel Reed's Avatar

Daniel Reed

@daniel-reed.bsky.social

Postdoctoral Researcher at Lund University in the Experimental Oncology Laboratory. Passionate about all things intravital imaging and uncovering the mechanisms of the tumour microenvironment

140 Followers  |  298 Following  |  1 Posts  |  Joined: 17.11.2024
Posts Following

Posts by Daniel Reed (@daniel-reed.bsky.social)

Preview
Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma - Nature Communications Improved understanding of the tumor ecosystem in glioblastoma is critical for developing new treatment strategies for the disease. Here, the authors identify pericytes as an active paracrine signaling...

New paper alert 🚨
We are delighted to present our latest paper in @natcomms.nature.com through fabulous work from co-first authors Sebastian Braun and Paulina Bolivar! Big thanks to all expert collaborators for taking this long journey with us!
Tweetorial in comments 🧡
www.nature.com/articles/s41...

09.12.2025 17:05 β€” πŸ‘ 14    πŸ” 6    πŸ’¬ 1    πŸ“Œ 0
Preview
The extracellular matrix in cancer: from understanding to targeting Significant advances in matrix biology research have enhanced our understanding of individual matrix components and extracellular matrix (ECM) signall…

New review paper written by Jess Chitty in the team just out in Trends in Cancer (@cp-trendscancer.bsky.social) (OpenAccess)
The extracellular matrix in cancer: from understanding to targeting
| β†’ www.sciencedirect.com/science/arti... ← |

03.06.2025 23:46 β€” πŸ‘ 9    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Preview
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response Temporal mass spectrometry proteomics, advanced microscopy, and in vivo modeling reveal nidogen-2 as a cotarget in PDAC.

Congratulations to @mbsanz.bsky.social MCR Paper of the Year 2024 Recipients, Brooke Pereira & Shona Ritchie, (co-led by @tcox.bsky.social ), for their latest work looking at the role of Nidogen-2 in pancreatic cancer published in Science Advances!

www.science.org/doi/10.1126/...

26.03.2025 22:20 β€” πŸ‘ 8    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Preview
Targeting the NPY/NPY1R signaling axis in mutant p53–dependent pancreatic cancer impairs metastasis Targeting NPY1R reduces mutant p53–dependent pancreatic cancer metastasis.

Excited to kick off my Bluesky posting by sharing this work by the lab looking at the role of neuropeptideY in #pancreaticcancer metastasis. An amazing piece of work and so thrilled to see it finally out!

@garvaninstitute.bsky.social

www.science.org/doi/10.1126/...

14.03.2025 00:47 β€” πŸ‘ 6    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0